施保利通联合利巴韦林注射液治疗轻症手足口病的效果观察  

Effects observation of mild hand,foot and mouth disease treatment with shibaolitong combined with ribavirin injection

作　　者：洪春泉 邹萍[1] 

机构地区：[1]江西省乐安县人民医院儿科,江西乐安344300

出　　处：《中国当代医药》2013年第35期72-73,共2页China Modern Medicine

摘　　要：目的观察施保利通联合巴韦林注射液治疗轻症手足口病的效果。方法选出手足口患儿62例,随机分为治疗组34例和对照组28例,对照组给予常规治疗加利巴韦林注射液静脉滴注,治疗组对照组的基础上加用施保利通联合治疗。结果治疗组患者的平均住院时间为(4.4±1.6)d,对照组患者的平均住院时间为(6.9±1.2)d,治疗组患者的皮疹消失时间为(2.5±1.4)d,对照组患者的皮疹消失时间为(5.3±2.1)d,治疗组时间均明显少于对照组,差异有统计学意义(P<0.05);治疗组总有效率(97.1%)明显优于对照组(75.0%),差异有统计学意义(P<0.05)。结论采用施保利通联合利巴韦林注射液治疗手足口病,能迅速缓解患者的临床症状,疗效确切,未见任何不良反应。Objective To observe the effects of mild hand,foot and mouth disease treatment with shibaolitong combined with ribavirin injection. Methods 62 cases of hand,foot and mouth disease children were selected and randomly divided into the treatment group in 34 cases and control group in 28 eases.The control group patients were given ribavirin injection intravenous infusion treatment bases on the conventional treatment,while the treatment group were added shibaolitong on the basis of control group. Results The average length of stay of the treatment group was（4.4±1.6）d,and control group of （6.9±1.2）d,the rash disappears time of the treatment group was （2.5±1.4）d,and control group of （5.3±2.1）d.The time of treatment group was significantly lower than that of the control group,with statistical significance （P〈 0.05）;The total effective rate of the treatment group was 97.1%,significantly better than 75.0% of control group,with statistical significance（P〈0.05）. Conclusion Taking shibaolitong combined with ribavirin injection to treat the hand,foot and mouth disease can rapidly relieve symptoms,effective,and dose not show any adverse reactions.

关 键 词：施保利通 利巴韦林注射液 手足口病 

分 类 号：R725.1[医药卫生—儿科]